Division of Pharmacoepidemiology and Pharmacoecomonics
The appropriate use of medications is a central aspect of health care. Each year, basic science research and biotechnology produce new treatments which hold the promise of major clinical benefit. However, these interventions also carry risks which must be rigorously measured and evaluated against the treatment's efficacy. Drugs are also a growing component of health care expenditures, and more attention is being drawn to the relation between the costs of medication and their benefits.
In 1998, the BWH Department of Medicine created the Division of Pharmacoepidemiology and Pharmacoeconomics to facilitate a wide range of activities related to the use and outcomes of medications, addressed from a variety of interdisciplinary perspectives. Its mission is to bring together the various specialties of medicine, epidemiology, biostatistics, health services research, and the social sciences to evaluate the effectiveness of existing and new prescription drugs in relation to their risks and costs; to study how medications are used by physicians and patients; and to develop methods to optimize prescription drug use.
Welcome message from Jerome L. Avorn, MD, Chief of the Division of Pharmacoepidemiology and Pharmacoecomonics.
The Department of Medicine at Brigham and Women’s Hospital is a recognized leader in patient care, teaching, and research at the local, national, and global level. Our physicians and clinicians provide the highest quality of patient care, with particular emphasis on patient-centered services, patient safety, and specialized innovative programs. We are a leader in medical education and at the forefront of clinical, translational, and basic research that has led to the prevention, diagnosis, and treatment of disease.